DE3461803D1
(en)
*
|
1983-05-23 |
1987-02-05 |
Pfizer |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin a and intermediates therefor
|
US4464527A
(en)
*
|
1983-06-30 |
1984-08-07 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
|
GR80277B
(en)
*
|
1983-09-06 |
1985-01-04 |
Pfizer |
Azahomoerythromycin b derivatives and intermediates therefor
|
US4465674A
(en)
*
|
1983-09-06 |
1984-08-14 |
Pfizer Inc. |
Azahomoerythromycin D derivative and intermediates therefor
|
US4518590A
(en)
*
|
1984-04-13 |
1985-05-21 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
|
YU44599B
(en)
*
|
1986-09-12 |
1990-10-31 |
Pliva Pharm & Chem Works |
Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
|
UA27040C2
(uk)
*
|
1987-07-09 |
2000-02-28 |
Пфайзер Інк. |
Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
|
WO1989002271A1
(en)
*
|
1987-09-10 |
1989-03-23 |
Pfizer |
Azithromycin and derivatives as antiprotozoal agents
|
MX13723A
(es)
*
|
1987-11-10 |
1993-05-01 |
Pfizer |
Procedimiento para preparar derivados de 9-desoxo-9a-alil- y propargil-9a-aza-9a-homoeritromicina a
|
US5837691A
(en)
*
|
1988-08-03 |
1998-11-17 |
Schering Corporation |
Actinomadura vulgaris subsp vulgaris and antimicrobial complex and antimicrobial
|
SI9011409A
(en)
*
|
1990-07-18 |
1995-10-31 |
Pliva Pharm & Chem Works |
O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
CA2064634C
(en)
|
1991-04-04 |
1998-08-04 |
James V. Heck |
9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
TW271400B
(da)
*
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
HRP930014A2
(en)
*
|
1993-01-08 |
1994-08-31 |
Pliva Pharm & Chem Works |
9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
ATE154806T1
(de)
*
|
1993-05-19 |
1997-07-15 |
Pfizer |
Zwischenprodukt für azithromycin
|
US5441939A
(en)
*
|
1994-03-04 |
1995-08-15 |
Pfizer Inc. |
3"-desmethoxy derivatives of erythromycin and azithromycin
|
HRP940251B1
(en)
*
|
1994-04-15 |
1998-12-31 |
Stjepan Mutak |
Process for the preparation of azithromycin dihydrochloride
|
US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
JP2977907B2
(ja)
*
|
1994-05-06 |
1999-11-15 |
ファイザー・インコーポレーテッド |
アジスロマイシンの放出調節された剤形
|
PT102006B
(pt)
*
|
1997-05-19 |
2000-06-30 |
Hovione Sociedade Quimica S A |
Novo processo de preparacao de azitromicina
|
HN1998000074A
(es)
*
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
HN1998000086A
(es)
*
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
JP2003512290A
(ja)
*
|
1997-09-10 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
家畜抗菌剤としての8a−アザライド
|
US6369035B1
(en)
*
|
1997-10-16 |
2002-04-09 |
Pliva, Farmaceutska Industrja, Dioni{Haeck Over (C)}Ko Dru{Haeck Over (S)}Tvo |
3,6-hemiketals from the class of 9A-azalides
|
DK0925789T4
(da)
*
|
1997-12-02 |
2009-07-13 |
Pfizer Prod Inc |
Anvendelse af azithromycin ved topisk behandling af öjeninfektioner
|
US6861411B1
(en)
*
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
AP9801420A0
(en)
*
|
1998-01-02 |
1998-12-31 |
Pfizer Prod Inc |
Novel macrolides.
|
AP1060A
(en)
|
1998-01-02 |
2002-04-23 |
Pfizer Prod Inc |
Novel erythromycin derivatives.
|
TW546302B
(en)
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
CA2245398C
(en)
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
EP1115732B1
(en)
|
1998-09-22 |
2005-06-29 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
TR200200436T2
(tr)
*
|
1998-11-03 |
2002-06-21 |
Pfizer Inc. |
Yeni makrolit antibiyotikler
|
UA70972C2
(uk)
*
|
1998-11-20 |
2004-11-15 |
Пфайзер Продактс Інк. |
13-членні азаліди і їх застосування як антибіотиків
|
PT1152765E
(pt)
|
1998-11-30 |
2004-12-31 |
Teva Pharma |
Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
|
ATE344269T1
(de)
|
1998-12-10 |
2006-11-15 |
Pfizer Prod Inc |
Carbamat und carbazat ketolid antibiotika
|
BR9916969A
(pt)
*
|
1999-01-27 |
2001-11-06 |
Pfizer Prod Inc |
Antibióticos cetólidos
|
US6239113B1
(en)
*
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
*
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6939861B2
(en)
*
|
1999-04-16 |
2005-09-06 |
Kosan Biosciences, Inc. |
Amido macrolides
|
AU3832100A
(en)
*
|
1999-05-24 |
2000-12-12 |
Pfizer Products Inc. |
13-methyl-erythromycin derivatives
|
US6465437B1
(en)
*
|
1999-06-30 |
2002-10-15 |
Pfizer Inc. |
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
|
PT1206476E
(pt)
*
|
1999-08-24 |
2006-05-31 |
Abbott Lab |
9a-azalidos com actividade antibacteriana
|
US6764996B1
(en)
|
1999-08-24 |
2004-07-20 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
EP1101769A3
(en)
|
1999-11-18 |
2001-10-24 |
Pfizer Products Inc. |
Nitrogen containing erythromycin derivatives
|
ES2177373B1
(es)
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
DE60133083D1
(de)
|
2000-01-04 |
2008-04-17 |
Teva Pharma |
Verfahren zur herstellung von azithromycin-dihydrat
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US20030213724A1
(en)
*
|
2000-03-20 |
2003-11-20 |
Sven Dobler |
Fragrance sampler insert
|
US6403776B1
(en)
|
2000-07-05 |
2002-06-11 |
Pfizer Inc. |
Synthesis of carbamate ketolide antibiotics
|
DE60026718T2
(de)
|
2000-07-25 |
2006-11-16 |
Laboratorio Silanes, S.A. De C.V. |
Einstufiges verfahren zur herstellung von 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle(11.2.11)hexadeca-1(2)-en-8-ona undeine neue form von 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
ATE306491T1
(de)
|
2000-08-23 |
2005-10-15 |
Wockhardt Ltd |
Verfahren zur herstellung von wasserfreiem azithromycin
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
CZ303343B6
(cs)
|
2000-11-27 |
2012-08-08 |
Sandoz Ag |
Zpusob prípravy azithromycinu ve forme monohydrátu
|
RU2263117C2
(ru)
|
2001-04-27 |
2005-10-27 |
Пфайзер Продактс Инк. |
Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
|
EA007618B1
(ru)
*
|
2001-05-22 |
2006-12-29 |
Пфайзер Продактс Инк. |
Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
|
EP1671979B1
(en)
|
2001-05-22 |
2008-08-13 |
Pfizer Products Inc. |
New Cristal Form of Azithromycin
|
US6861413B2
(en)
*
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
SK1012004A3
(sk)
*
|
2001-08-21 |
2005-04-01 |
Pfizer Products Inc. |
Použitie azitromycínu na výrobu liečiva na liečenie respiračných infekcií u človeka
|
DE60232005D1
(de)
*
|
2001-10-18 |
2009-05-28 |
Teva Pharma |
Stabilisierte azithromycin-zusammensetzungen
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
BR0215175A
(pt)
*
|
2001-12-21 |
2004-12-28 |
Pfizer Prod Inc |
Métodos para a granulação úmida de azitromicina
|
NZ532707A
(en)
*
|
2001-12-21 |
2006-07-28 |
Pfizer Prod Inc |
Directly compressible formulations of azithromycin
|
US8063021B2
(en)
*
|
2002-01-17 |
2011-11-22 |
Kosan Biosciences Incorporated |
Ketolide anti-infective compounds
|
JP2005526020A
(ja)
*
|
2002-02-01 |
2005-09-02 |
ファイザー・プロダクツ・インク |
アジスロマイシンの乾式造粒配合物
|
CA2476423A1
(en)
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
EP1483579A4
(en)
*
|
2002-02-15 |
2006-07-12 |
Merckle Gmbh |
CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
|
US20040186063A1
(en)
*
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
NZ535355A
(en)
*
|
2002-02-15 |
2007-09-28 |
Merckle Gmbh |
Antibiotic conjugates
|
EP1479687A4
(en)
*
|
2002-02-26 |
2006-01-04 |
Meiji Seika Kaisha |
A NEW LOW-GYLIC CYCLIC AZALIDE, A NEW 16-LOW CYCLIC DIAZALID DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
AU2003245504A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
CN100577681C
(zh)
*
|
2002-07-08 |
2010-01-06 |
葛兰素伊斯特拉齐瓦基森塔萨格勒布公司 |
用于治疗炎性疾病和病症的新化合物、组合物和方法
|
JP4530851B2
(ja)
*
|
2002-07-08 |
2010-08-25 |
グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ |
ステロイド/非ステロイド抗炎症活性分子、抗新生物活性分子および抗ウイルス活性分子用担体としての新規な化合物、組成物
|
BR0312584A
(pt)
*
|
2002-07-08 |
2005-04-12 |
Pliva Istrazivacki Inst D O O |
Novas substâncias anti-inflamatórias não-esteróides, compostos e métodos para o uso das mesmas
|
HRP20020885B1
(en)
*
|
2002-11-11 |
2007-05-31 |
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. |
SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
|
HRP20020991A2
(en)
*
|
2002-12-12 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
|
CA2801100A1
(en)
|
2003-03-10 |
2004-09-23 |
Optimer Pharmaceuticals, Inc. |
Macrolides and processes for their preparation
|
EP1606299A1
(en)
*
|
2003-03-25 |
2005-12-21 |
Teva Pharmaceutical Industries Ltd. |
Degradation products of azithromycin, and methods for their identification
|
ES2220229B1
(es)
*
|
2003-05-29 |
2005-10-16 |
Quimica Sintetica, S.A. |
Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
|
EP1638529B1
(en)
*
|
2003-06-16 |
2016-08-10 |
ANDRX Pharmaceuticals, LLC. |
Oral extended-release composition
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
EP1648418A4
(en)
|
2003-07-21 |
2011-11-16 |
Middlebrook Pharmaceuticals Inc |
ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
|
AU2004258953B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
US8313776B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
EP1653925A1
(en)
|
2003-08-11 |
2006-05-10 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
EP1661904A1
(en)
*
|
2003-08-22 |
2006-05-31 |
Meiji Seika Kaisha Ltd. |
Novel azalide and azalactam derivatives and process for the production of the same
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
CN1313476C
(zh)
*
|
2003-09-09 |
2007-05-02 |
上海新先锋药业有限公司 |
阿奇霉素的水溶性磷酸盐的注射剂型及其制备方法
|
WO2005027877A1
(en)
|
2003-09-15 |
2005-03-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
US7276487B2
(en)
*
|
2003-09-23 |
2007-10-02 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-bicyclic 9a-azalide derivatives
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
CA2549225A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
EP1691787B1
(en)
|
2003-12-04 |
2008-07-02 |
Pfizer Products Inc. |
Method for making pharmaceutical multiparticulates
|
WO2005053653A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
BRPI0416534A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
composições multiparticuladas com estabilidade melhorada
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
RU2006119453A
(ru)
*
|
2003-12-04 |
2007-12-20 |
Пфайзер Продактс Инк. (Us) |
Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
JP3933683B2
(ja)
*
|
2004-07-02 |
2007-06-20 |
わかもと製薬株式会社 |
アジスロマイシン含有水性医薬組成物及びその調製方法
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
MX2007001669A
(es)
*
|
2004-08-12 |
2007-04-10 |
Glaxosmithkline Zagreb |
Uso de conjugados especificos celulares para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal.
|
US20060183696A1
(en)
*
|
2004-08-12 |
2006-08-17 |
Pliva-Istrazivacki Institut D.O.O. |
Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
PT1836211E
(pt)
|
2004-12-21 |
2010-04-08 |
Pfizer Prod Inc |
Macrólidos
|
CA2591744A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Pfizer Products Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
US20090318375A1
(en)
*
|
2005-06-08 |
2009-12-24 |
Hanmi Pharm Co., Ltd |
Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
|
WO2007012464A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Merckle Gmbh |
Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
JP5015016B2
(ja)
*
|
2006-02-07 |
2012-08-29 |
大正製薬株式会社 |
10a−アザライド化合物
|
US8299052B2
(en)
*
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
EP2177526A4
(en)
|
2007-08-06 |
2012-08-22 |
Taisho Pharmaceutical Co Ltd |
10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
|
US8124123B2
(en)
*
|
2007-09-05 |
2012-02-28 |
Dow Pharmaceutical Sciences, Inc. |
Controlled release azithromycin solid dosages forms
|
CN105732745A
(zh)
|
2007-10-25 |
2016-07-06 |
森普拉制药公司 |
大环内酯类抗菌剂的制备方法
|
US8299035B2
(en)
|
2008-05-15 |
2012-10-30 |
Taisho Pharmaceutucal Co., Ltd. |
10a-azalide compound having 4-membered ring structure
|
CN107854477A
(zh)
|
2008-10-24 |
2018-03-30 |
森普拉制药公司 |
使用含***的大环内酯治疗抗性疾病的方法
|
US20170128481A9
(en)
|
2009-03-06 |
2017-05-11 |
Insite Vision Corporation |
Ocular treatment with reduced intraocular pressure
|
BRPI1009823A2
(pt)
|
2009-03-13 |
2019-09-24 |
Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 |
"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
|
US9937194B1
(en)
|
2009-06-12 |
2018-04-10 |
Cempra Pharmaceuticals, Inc. |
Compounds and methods for treating inflammatory diseases
|
WO2011015219A1
(en)
|
2009-08-06 |
2011-02-10 |
Shifa Pharmed Industrial Group Co. |
Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
|
WO2011032052A1
(en)
|
2009-09-10 |
2011-03-17 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and mac diseases
|
EP2550286B1
(en)
|
2010-03-22 |
2015-12-09 |
Cempra Pharmaceuticals, Inc. |
Crystalline forms of a macrolide, and uses therefor
|
PL2571506T3
(pl)
|
2010-05-20 |
2017-10-31 |
Cempra Pharmaceuticals Inc |
Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
|
KR20180110181A
(ko)
|
2010-09-10 |
2018-10-08 |
셈프라 파마슈티컬스, 인크. |
질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
|
AR085286A1
(es)
|
2011-02-21 |
2013-09-18 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrolido sustituido en la posicion c-4
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
IN2014DN08939A
(da)
|
2012-03-27 |
2015-05-22 |
Cempra Pharmaceuticals Inc |
|
EA201500699A1
(ru)
|
2012-12-24 |
2015-12-30 |
Рамот Эт Тель-Авив Юниверсити Лтд. |
Агенты для лечения генетических заболеваний, возникающих в результате нонсенс-мутаций, и способы идентификации этих агентов
|
AU2014239959A1
(en)
|
2013-03-14 |
2015-10-01 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
EP2968384A4
(en)
|
2013-03-15 |
2017-02-15 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
CN103965273B
(zh)
|
2013-08-23 |
2016-05-25 |
普莱柯生物工程股份有限公司 |
一种大环内酯类化合物
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
AR102810A1
(es)
|
2014-08-18 |
2017-03-29 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrólido sustituido en la posición c-4
|
CA3053993A1
(en)
|
2017-02-22 |
2018-08-30 |
Immune System Regulation Holding Ab |
Novel immune stimulating compound
|
US10919927B2
(en)
|
2017-02-22 |
2021-02-16 |
ISR Immune System Regulation Holding AB (publ) |
Immune stimulating macrolide
|
CN116507362A
(zh)
|
2020-09-03 |
2023-07-28 |
Isr免疫***调节控股公共有限公司 |
包含抗原和tlr2激动剂的疫苗
|